Jun 292020
 

By operator Feed Up

Talent4Boards - Great Talent builds Great Boards

– UK, London – Shield Therapeutics plc (LON: STX), a commercial-stage, pharmaceutical company with a focus on addressing iron deficiency with its lead product Feraccru/Accrufer, today announced the appointment of Dr Christian Schweiger to its Board as a Non-Executive Director effective immediately. “I am delighted that Christian has agreed to ...

Shield Therapeutics appoints Dr Christian Schweiger to its Board as Non-Executive Director

Shield Therapeutics appoints Dr Christian Schweiger to its Board as Non-Executive Director

From:: Shield Therapeutics appoints Dr Christian Schweiger to its Board as Non-Executive Director

Sorry, the comment form is closed at this time.